No. 80: CR Bard

Chris Newmarker

August 25, 2016

1 Min Read
No. 80: CR Bard

No. 80 CR Bard

Innovation Premium: 42%

After years of development and clinical research, sales of CR Bard's Lutonix drug coated balloon exceeded the company's expectations during its first full year of U.S. sales in 2015, according to the company's most recent annual report. With all sizes 5F, the Lutonix is touted as the lowest profile drug coated balloon on the U.S. market.


CR Bard also boasts that 38 of the 40 products it launched in 2015 were the results of organic R&D efforts. 

Continue >>

[Image of Lutonix 035 courtesy of CR Bard]

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like